Detailansicht

Wissensnetz

Person

Martin Bornhäuser (1966-)

Arzt

Name	Martin Bornhäuser
Zeit	1966- (Lebensdaten)
Ort	Dresden (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf) Onkologe Hochschullehrer
Weitere Angaben	Professor für Hämatologie, Onkologie Vorsitzender Tumorzentrum Dresden (TZ) Geschäftsführender Direktor Nationales Centrum für Tumorerkrankungen Standort Dresden (NCT Dresden)
Quelle	http://stemcell-lab-mk1dresden.de/wordpress/forschung/prof-dr-martin-bornhaeuser/ (Stand: 21.09.2018)
Datensatztyp	Person
GND-Nummer	1167559118
Datensatz-ID	1167559118
Beteiligt an alle anzeigen Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study How to customize common data models for rare diseases: an OMOP-based implementation and lessons learned Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms Prognostic impact of CEBPA mutational subgroups in adult AML A Self-Assembled Matrix System for Cell-Bioengineering Applications in Different Dimensions, Scales, and Geometries Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML : Residual Morphological Blast Count Determines the Risk of Relapse Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears Die psychoonkologische Versorgungssituation von Patienten mit Weichteilsarkomen : Resultate einer deutschen multizentrischen Beobachtungsstudie (PROSa) Distress in soft‐tissue sarcoma and gastrointestinal stromal tumours patients - Results of a German multicentre observational study (PROSa) Functional analyses of extremely premature baboon lung-derived MSCs after prophylactic cell therapy administration Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation Investigation of metabolic plasticity in melanoma Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations Potential of TCR sequencing in graft-versus-host disease Profound sympathetic neuropathy in the bone marrow of patients with acute myeloid leukemia Regulation of Proliferation of Alveolar Macrophages in Acute Respiratory Distress Syndrome Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia The role of CD105 deficiency on the bone marrow vasculature : a time-lapse analysis Profound sympathetic neuropathy in the bone marrow of patients with acute myeloid leukemia Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification M‐CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study Alterations of cohesin complex genes in acute myeloid leukemia : differential co-mutations, clinical presentation and impact on outcome Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome Application of mathematical modelling to describe and predict treatment dynamics in patients with NPM1-mutated Acute Myeloid Leukaemia (AML) Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients over 60 years of age: a prospective phase II study Bidirectional interference of mesenchymal stromal cells and anti-leukemic effector cells within the bone marrow microenvironment Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia Reduced 8-Gray compared to standard 12-Gray Total Body Irradiation for allogeneic transplantation in first remission acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of the EBMT Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome Potential of TCR sequencing in graft-versus-host disease Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic Die psychoonkologische Versorgungssituation von Patienten mit Weichteilsarkomen : Resultate einer deutschen multizentrischen Beobachtungsstudie (PROSa) Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears A Self‐Assembled Matrix System for Cell‐Bioengineering Applications in Different Dimensions, Scales, and Geometries Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels = Die Rolle von Galectin-9 im duktalen Adenokarzinom des Pankreas Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study Financial toxicity in sarcoma patients and survivors in Germany : results from the multicenter PROSa study

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Martin Bornhäuser (1966-)

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study

How to customize common data models for rare diseases: an OMOP-based implementation and lessons learned

Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy

Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients

Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms

Prognostic impact of CEBPA mutational subgroups in adult AML

A Self-Assembled Matrix System for Cell-Bioengineering Applications in Different Dimensions, Scales, and Geometries

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML : Residual Morphological Blast Count Determines the Risk of Relapse

Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients

Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears

Die psychoonkologische Versorgungssituation von Patienten mit Weichteilsarkomen : Resultate einer deutschen multizentrischen Beobachtungsstudie (PROSa)

Distress in soft‐tissue sarcoma and gastrointestinal stromal tumours patients - Results of a German multicentre observational study (PROSa)

Functional analyses of extremely premature baboon lung-derived MSCs after prophylactic cell therapy administration

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Investigation of metabolic plasticity in melanoma

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

Potential of TCR sequencing in graft-versus-host disease

Profound sympathetic neuropathy in the bone marrow of patients with acute myeloid leukemia

Regulation of Proliferation of Alveolar Macrophages in Acute Respiratory Distress Syndrome

Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia

The role of CD105 deficiency on the bone marrow vasculature : a time-lapse analysis

Profound sympathetic neuropathy in the bone marrow of patients with acute myeloid leukemia

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia

Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial

Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

M‐CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation

Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study

Alterations of cohesin complex genes in acute myeloid leukemia : differential co-mutations, clinical presentation and impact on outcome

Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome

Application of mathematical modelling to describe and predict treatment dynamics in patients with NPM1-mutated Acute Myeloid Leukaemia (AML)

Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients over 60 years of age: a prospective phase II study

Bidirectional interference of mesenchymal stromal cells and anti-leukemic effector cells within the bone marrow microenvironment

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia

Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4

Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia

Reduced 8-Gray compared to standard 12-Gray Total Body Irradiation for allogeneic transplantation in first remission acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of the EBMT

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome

Potential of TCR sequencing in graft-versus-host disease

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Die psychoonkologische Versorgungssituation von Patienten mit Weichteilsarkomen : Resultate einer deutschen multizentrischen Beobachtungsstudie (PROSa)

Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears

A Self‐Assembled Matrix System for Cell‐Bioengineering Applications in Different Dimensions, Scales, and Geometries

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels = Die Rolle von Galectin-9 im duktalen Adenokarzinom des Pankreas

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Financial toxicity in sarcoma patients and survivors in Germany : results from the multicenter PROSa study